XML 69 R33.htm IDEA: XBRL DOCUMENT
v3.20.2

Collaboration and License Agreements - Takeda Pharmaceuticals U.S.A., Inc - Additional Information (Detail) - Takeda License Agreement - License and Co-Funding Agreement - Subsequent Event $ in Millions | Oct. 07, 2020 USD ($) Obligation Bundle
--- | ---
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Agreement date | Oct. 07, 2020
Ratio of Profit Sharing Structure for United States Commercialization | 50/50 profit sharing
Cash received as due under collaboration agreement | $ 300.0
Development regulatory and sales milestones payments | $ 740.0
Number of distinct bundle | Bundle | 1
Number of distinct performance obligations | Obligation | 1
Initial transaction price | $ 300.0
Minimum |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Percentage of eligible to receive tiered royalties on net sales | 20.00%
Maximum |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Percentage of eligible to receive tiered royalties on net sales | 25.00%
Development regulatory and sales milestones payments | $ 740.0

X
- Definition Agreement date. + References No definition available. + Details
Name: | arwr_AgreementDate
Namespace Prefix: | arwr_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash receivable as upfront payment due under collaboration agreement. + References No definition available. + Details
Name: | arwr_CashReceivableAsUpfrontPaymentDueUnderCollaborationAgreement
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Development regulatory and sales milestones payments. + References No definition available. + Details
Name: | arwr_DevelopmentRegulatoryAndSalesMilestonesPayments
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Initial transaction price. + References No definition available. + Details
Name: | arwr_InitialTransactionPrice
Namespace Prefix: | arwr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of distinct bundle. + References No definition available. + Details
Name: | arwr_NumberOfDistinctBundle
Namespace Prefix: | arwr_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of distinct performance obligations. + References No definition available. + Details
Name: | arwr_NumberOfDistinctPerformanceObligations
Namespace Prefix: | arwr_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of eligible to receive tiered royalties on net sales. + References No definition available. + Details
Name: | arwr_PercentageOfEligibleToReceiveTieredRoyaltiesOnNetSales
Namespace Prefix: | arwr_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Ratio of profit sharing structure for commercialization. + References No definition available. + Details
Name: | arwr_RatioOfProfitSharingStructureForCommercialization
Namespace Prefix: | arwr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=arwr_TakedaPharmaceuticalsUnitedStatesOfAmericaIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=arwr_LicenseAndCoFundingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |